Novo CEO pressed by Senate to chop prices of obesity, diabetes medication CEO Lars Fruergaard Jørgensen informed lawmakers the business would contemplate new talks with insurers concerning the list charges of Wegovy and copyright whenever they pledge to maintain the medicines on their own formularies. Expenditure in digital wellbeing companies https://eduardoulbrh.p2blogs.com/29899631/an-unbiased-view-of-healthcare-news